Recent successes of theranostics for treatment of neuroendocrine and prostate cancer has ignited interest in this treatment for refractory cancers.

The formation and dynamics of nanotubes are increasingly recognized to play important roles in a multitude of biological progresses. We demonstrated the role of nanotube dynamics in autophagic lysosome reformation (ALR) during autophagy and mitochondrial network remodelling with single-molecule in vitro reconstitution assay and super-resolution fluorescent microscopy.

There has been renewed interest in gene therapy driven by an exciting yet modest number of successful clinical applications for monogenic diseases. Although monogenic diseases are a logical target, cardiac arrhythmias represent a group of conditions amenable to gene therapy because of focal therapeutic targets (biological pacemakers, nodal conduction) or bystander effects on non-transduced cells due to electrical coupling.